In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Editorial - October 2021

ESC Working Group on Myocardial and Pericardial Diseases

Dear Members

I hope you enjoyed the Annual Meeting of the ESC WG on Myocardial and Pericardial Diseases. We tried to bring together the 3 scientific fields of our WG, the myocardial, pericardial and inflammatory diseases of the heart. Whilst the understanding of discrete pathogenetic mechanisms is progressing, the insight into some common paradigms of disease is also growing. Some of the common disease models are related to the relationships between genotypes and phenotypes and the identification of the factors which influence this association. When sufficient evidence is acquired and is confidently interpreted, it will all translate into major improvement of the patients’ care. However, science is not enough to improve patient’s lives. Healthcare systems need to review their efficiency, embed new technology and use their resources in a patient-centric way. This is entirely important for chronic diseases and myocardial and pericardial diseases are often good examples of long-term diseases.

For those of you who attended the meeting, please remember that recorded sessions are available for one month on the meeting platform. Then, they will be accessible to all on the ESC Working Group M&PD pages. Enjoy!

On behalf of the Working Group nucleus,

Antonis Pantazis, Chairperson 2020-2022


>> Retrieve other Working Group news